Adherent dendritic cells expressing high levels of interleukin-10 and low levels of interleukin-12 induce antigen-specific tolerance to experimental autoimmune encephalomyelitis

Immunology

Volumn 101, Issue 3, 2000, Pages 397-403

  Yang, J S ^a   Xu, L Y ^a   Huang, Y M ^a   Van Der Meide, P H ^b   Link, H ^a   Xiao, B G ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 12; MYELIN BASIC PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

ANIMALS; ANTIGEN PRESENTATION; APOPTOSIS; CELL ADHESION; CELL DIVISION; DENDRITIC CELLS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; IMMUNE TOLERANCE; IMMUNOPHENOTYPING; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; LYMPH NODES; MALE; MYELIN BASIC PROTEINS; NITRIC OXIDE; PEPTIDE FRAGMENTS; RATS; RATS, INBRED LEW; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 0033653874     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2000.00115.x     Document Type: Article

References (33)

1. Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion
2. Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8 (+) T cells
3. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo
4. CD8 alpha+ and CD8alpha- subclasses of dendritic cells direct the development of distinct T helper cells in vivo
5. Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage
6. Increased transforming growth factor-beta, interleukin-4, and interferon-gamma in multiple sclerosis
7. Mechanisms of recovery from experimental allergic encephalomyelitis induced with myelin basic protein peptide 68-86 in Lewis rats: A role for dendritic cells in inducing apoptosis of CD4+T cells
8. Immunobiology of dendritic cells
9. Three populations of mouse lymph node dendritic cells with different origins and dynamics
10. Antigen-pulsed CD8α dendritic cells generate an immune response after subcutaneous injection without homing to the draining lymph node
11. Stimulatory and inhibitory differentiation of human myeloid dendritic cells
12. Induction of tolerance by IL-10-treated dendritic cells
13. Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells
14. Retroviral delivery of viral interleukin-10 into myeloid dendritic cells markedly inhibits their allostimulatory activity and promotes the induction of T-cell hyporesponsiveness
15. CD40-deficient dendritic cells producing interleukin-10, but not interleukin-12, induce T-cell hyporesponsiveness in vitro and prevent acute allograft rejection
16. Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity
17. T cell priming by type 1 and type 2 polarized dendritic cells: The concept of a third signal
18. The induction of tolerance by dendritic cells that have captured apoptotic cells
19. Specific immunoregulation of the induction and effector stages of relapsing EAE via neuroantigen-specific tolerance induction
20. Antigen-specific tolerance as a therapy for experimental autoimmune encephalomyelitis
21. Nasal administration of myelin basic protein prevents relapsing experimental autoimmune encephalomyelitis in DA rats by activating regulatory cells expressing IL-4 and TGF-beta mRNA
22. Decrease of LFA-1 is associated with upregulation of TGF-beta in CD4 (+) T cell clones derived from rats nasally tolerized against experimental autoimmune myasthenia gravis
23. Cellular mRNA expression of interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) in rats nasally tolerized against experimental autoimmune myasthenia gravis (EAMG)
24. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis
25. Mechanisms of nasal tolerance induction in experimental autoimmune myasthenia gravis: Identification of regulatory cells
26. IL-4 is a differentiation factor for transforming growth factor-beta secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomylitis
27. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor β after antigen-specific triggering
28. IL-12 protects from a Th-1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon-γ, nitric oxide, and apoptosis
29. IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis
30. Nitric oxide is a potential down-regulating molecule in autoimmune disease: Inhibition of nitric oxide production renders PVG rats highly susceptible to EAE
31. Nitric oxide plays a critical role in the recovery of Lewis rats from experimental autoimmune encephalomyelitis and the maintenance of resistance to reinduction
32. IFN-γ is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: A possible role for nitric oxide
33. A subset of dendritic cells kills-CD4 T cells via Fas/Fas-ligand-induced apoptosis